Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-18 receptor accessory protein (IL18RAP) is an essential accessory subunit of the interleukin-18 (IL-18) receptor complex, which is part of the interleukin-1 receptor (IL-1R) superfamily[1][4][7]. IL18RAP does not directly bind IL-18 but forms a heterodimeric complex with IL-18 receptor alpha (IL18R1), enabling high-affinity ligand binding and promoting downstream signal transduction upon cytokine engagement[2][4][7]. This leads to the recruitment of the adaptor MyD88 and activation of pro-inflammatory transcription factors such as NF-κB and kinases including JNK, ultimately influencing Th1 immune responses, NK cell function, and neutrophil activation[2][5]. IL18RAP genetic variants and expression dysregulation are associated with various inflammatory, autoimmune, infectious diseases, and a range of cancers, and it is under evaluation as a disease activity biomarker and potential immunotherapeutic target[2][5].
Blocking antibodies may inhibit IL-18-mediated signaling by preventing complex formation or downstream activation of MyD88, NF-κB, and MAPK pathways[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-18 receptor accessory protein (IL18RAP).